tacrolimus (FK506)

DRUG3 trials

Sponsors

Sun Yat-sen University, Novartis Pharmaceuticals

Conditions

Chronic Renal FailureInduction PhaseKidney DiseasesLupus NephritisMaintenance PhaseNephrotic SyndromeTacrolimus

Phase 3

Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

CompletedNCT00615173

Sun Yat-sen UniversityInduction Phase, Kidney Diseases, Lupus Nephritis +2

Start: 2006-07-31End: 2008-09-30Updated: 2008-10-29

Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)

CompletedNCT00615667

Sun Yat-sen UniversityKidney Diseases, Nephrotic Syndrome, Tacrolimus

Start: 2006-06-30End: 2008-09-30Updated: 2016-04-20

Phase 4

Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients

CompletedNCT00965094

Novartis PharmaceuticalsChronic Renal Failure

Start: 2009-12-31End: 2013-06-30Updated: 2014-08-15